- Advanced search
|International Nonproprietary Names|
|Search PubMed clinical trials||benralizumab|
|Search PubMed titles||benralizumab|
|Search PubMed titles/abstracts||benralizumab|
|Benralizumab is a humanized, afucosylated mAb targeting the IL5Rα which is expressed by cells of the eosinophil lineage. The antibody is afucosylated (ie has fucose containing oligosaccharide side-chains removed) to improve structure, stability, and biological function.
Peptide sequence information for this antibody is available from its IMGT/mAb-DB link.